Cargando…
Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
BACKGROUND: Metformin is a widely used first-line drug for treatment of type 2 diabetes. Despite its advantages, metformin has variable therapeutic effects, contraindications, and side effects. Here, for the very first time, we investigate the short-term effect of metformin on the composition of hea...
Autores principales: | Elbere, Ilze, Kalnina, Ineta, Silamikelis, Ivars, Konrade, Ilze, Zaharenko, Linda, Sekace, Kristine, Radovica-Spalvina, Ilze, Fridmanis, Davids, Gudra, Dita, Pirags, Valdis, Klovins, Janis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160085/ https://www.ncbi.nlm.nih.gov/pubmed/30261008 http://dx.doi.org/10.1371/journal.pone.0204317 |
Ejemplares similares
-
Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals
por: Elbere, Ilze, et al.
Publicado: (2018) -
Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals
por: Ustinova, Monta, et al.
Publicado: (2019) -
Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients
por: Elbere, Ilze, et al.
Publicado: (2020) -
Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response
por: Ustinova, Monta, et al.
Publicado: (2020) -
A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies
por: Gudra, Dita, et al.
Publicado: (2019)